- Home
- CCJ vs DXCM Comparison
CCJ vs DXCM Comparison
Compare CCJ & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CCJ | DXCM |
|---|---|---|
| Founded | 1987 | 1999 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Other Metals and Minerals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.4B | 25.9B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | CCJ | DXCM |
|---|---|---|
| Price | $118.27 | $71.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 22 |
| Target Price | ★ $114.38 | $86.41 |
| AVG Volume (30 Days) | 3.5M | ★ 4.8M |
| Earning Date | 02-13-2026 | 02-12-2026 |
| Dividend Yield | ★ 0.15% | N/A |
| EPS Growth | ★ 364.36 | 7.75 |
| EPS | 0.87 | ★ 1.80 |
| Revenue | $2,487,042,049.00 | ★ $4,515,900,000.00 |
| Revenue This Year | $10.50 | $17.41 |
| Revenue Next Year | $8.66 | $12.73 |
| P/E Ratio | $133.49 | ★ $39.36 |
| Revenue Growth | ★ 23.88 | 14.21 |
| 52 Week Low | $35.00 | $54.11 |
| 52 Week High | $118.54 | $93.25 |
Technical Indicators
Market Signals| Indicator | CCJ | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 80.43 | 63.89 |
| Support Level | $106.87 | $68.54 |
| Resistance Level | $118.54 | $71.28 |
| Average True Range (ATR) | 4.28 | 2.42 |
| MACD | 1.51 | 0.14 |
| Stochastic Oscillator | 92.35 | 87.00 |
Price Performance
Historical ComparisonAbout CCJ Cameco Corporation
Cameco Corp is a provider of uranium needed to generate clean, reliable baseload electricity around the globe. one of those uranium producers. It has three reportable segments, Uranium, Fuel Services, and Westinghouse. It derives maximum revenue from the Westinghouse Segment. It has some projects namely; Millennium, Yeelirrie, Kintyre, and Exploration. The company operates in Canada, Kazakhstan, Germany, Australia, and the United States.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.